Migration of eosinophils through basement membrane components in vitro: role of matrix metalloproteinase-9.
暂无分享,去创建一个
[1] H. Kita,et al. Transmigration of eosinophils through basement membrane components in vitro: synergistic effects of platelet-activating factor and eosinophil-active cytokines. , 1997, American journal of respiratory cell and molecular biology.
[2] C. Delacourt,et al. Role of gelatinase B and elastase in human polymorphonuclear neutrophil migration across basement membrane. , 1996, American journal of respiratory cell and molecular biology.
[3] S. Hauser,et al. Stimulus specificity of matrix metalloproteinase dependence of human T cell migration through a model basement membrane. , 1996, Journal of immunology.
[4] J. Hogg,et al. Nonmuscular airway obstruction and asthma. , 1995, American journal of respiratory and critical care medicine.
[5] E. Waubant,et al. T cell gelatinases mediate basement membrane transmigration in vitro. , 1995, Journal of immunology.
[6] R. Schleimer,et al. The role of adhesion molecules in human eosinophil and basophil recruitment. , 1994, The Journal of allergy and clinical immunology.
[7] M. Ebisawa,et al. Eosinophil transendothelial migration induced by cytokines. III. Effect of the chemokine RANTES. , 1994, Journal of immunology.
[8] J. O'Connell,et al. Regulation of Matrix Metalloproteinase Activity a , 1994, Annals of the New York Academy of Sciences.
[9] R. Hoffman,et al. Matrix metalloproteinase inhibitor BB-94 (batimastat) inhibits human colon tumor growth and spread in a patient-like orthotopic model in nude mice. , 1994, Cancer research.
[10] N. Katunuma,et al. Inhibitors of chymotrypsin-like proteases inhibit eosinophil peroxidase release from activated human eosinophils. , 1994, Archives of biochemistry and biophysics.
[11] H. Kita,et al. CD11b/CD18 (Mac-1) is required for degranulation of human eosinophils induced by human recombinant granulocyte-macrophage colony-stimulating factor and platelet-activating factor. , 1994, Journal of immunology.
[12] W. Parks,et al. 92-kD gelatinase is produced by eosinophils at the site of blister formation in bullous pemphigoid and cleaves the extracellular domain of recombinant 180-kD bullous pemphigoid autoantigen. , 1994, The Journal of clinical investigation.
[13] H. Kita,et al. Ammonium chloride exposure inhibits cytokine-mediated eosinophil survival. , 1994, Journal of immunological methods.
[14] C. Soria,et al. Activation of the 92 kDa type IV collagenase by tissue kallikrein , 1993, Journal of cellular physiology.
[15] U. Moll,et al. Inhibition of matrix metalloproteinase 9 activation by a specific monoclonal antibody. , 1993, Hybridoma.
[16] D. Woolley,et al. Catabolism of intact type VI collagen microfibrils: susceptibility to degradation by serine proteinases. , 1993, Biochemical and biophysical research communications.
[17] K. Naka,et al. Matrix metalloproteinase 9 (92-kDa gelatinase/type IV collagenase) from HT 1080 human fibrosarcoma cells. Purification and activation of the precursor and enzymic properties. , 1992, The Journal of biological chemistry.
[18] A. Eisen,et al. Expression of 92-kDa type IV collagenase mRNA by eosinophils associated with basal cell carcinoma. , 1992, The Journal of investigative dermatology.
[19] P. Jeffery,et al. Effects of treatment on airway inflammation and thickening of basement membrane reticular collagen in asthma. A quantitative light and electron microscopic study. , 1992, The American review of respiratory disease.
[20] G Murphy,et al. A novel coumarin‐labelled peptide for sensitive continuous assays of the matrix metalloproteinases , 1992, FEBS letters.
[21] M. D. de Santi,et al. Identification of elastase in human eosinophils: immunolocalization, isolation, and partial characterization. , 1992, Archives of biochemistry and biophysics.
[22] J. Bousquet,et al. Eosinophilic inflammation in asthma. , 1990, The New England journal of medicine.
[23] A. Eisen,et al. SV40-transformed human lung fibroblasts secrete a 92-kDa type IV collagenase which is identical to that secreted by normal human macrophages. , 1989, The Journal of biological chemistry.
[24] R. Schleimer,et al. Studies on the adhesive interaction between purified human eosinophils and cultured vascular endothelial cells. , 1988, Journal of immunology.
[25] A. Wardlaw,et al. Platelet-activating factor. A potent chemotactic and chemokinetic factor for human eosinophils. , 1986, The Journal of clinical investigation.
[26] G. Laurie,et al. Basement membrane complexes with biological activity. , 1986, Biochemistry.
[27] H. Sampson,et al. Dermal deposition of eosinophil-granule major basic protein in atopic dermatitis. Comparison with onchocerciasis. , 1985, The New England journal of medicine.
[28] A. Jesaitis,et al. A continuous, spectroscopic analysis of the kinetics of elastase secretion by neutrophils. The dependence of secretion upon receptor occupancy. , 1982, The Journal of biological chemistry.
[29] L. Liotta,et al. Metastatic potential correlates with enzymatic degradation of basement membrane collagen , 1980, Nature.
[30] E. Dowdle,et al. Electrophoretic analysis of plasminogen activators in polyacrylamide gels containing sodium dodecyl sulfate and copolymerized substrates. , 1980, Analytical biochemistry.
[31] McDowell Em,et al. Histologic fixatives suitable for diagnostic light and electron microscopy. , 1976 .
[32] A. Spurr. A low-viscosity epoxy resin embedding medium for electron microscopy. , 1969, Journal of ultrastructure research.